FDA won't hold companies responsible for independent user content on their social media properties

U.S. pharmaceutical companies may have gotten off easy compared to other areas of the world, said Peter Pitts, president of the Center for Medicine in the Public Interest and a former associate commissioner at the FDA.

The European Court of Justice recently ruled that online remarks about drugs posted by a third party on the manufacturer's Web property could constitute advertising, even though the post's author has no connection with the product's manufacturer or marketer.

“That's carte blanche for an almost complete gag order on anyone who wants to discuss anything to do with medicines,” Pitts said.
Sign Up for Our Email Newsletter

RECENT NEWS

War on Vaping Threatens Public Health

War on Vaping Threatens Public Health

Will the government hamstring what is potentially the most important public health innovation of the 21st century?...  Read more

PBMs Are Hogging Our Drug Discounts

PBMs Are Hogging Our Drug Discounts

PBMs are knowingly profiting off the backs of American patients, pharmacists, and innovators....  Read more

Advancing 21st Century Pain Management Conference (August 17, 2018)

Advancing 21st Century Pain Management Conference (August 17, 2018)

CMPI conference: Advancing 21st Century Pain Management Keynote Speaker: FDA Commissioner Scott Gottlieb...  Read more

DRUGWONKS BLOG